Vasсulitis of skin at the patient with a chronic hepatitis C, the admixed сryoglobulinemia and activity current chronic CMV infection (the description of a clinical case)
https://doi.org/10.22625/2072-6732-2011-3-3-114-119
About the Authors
D. L. SulimaRussian Federation
O. V. Gorchakova
Russian Federation
N. V. Sabadash
Russian Federation
V. E. Karev
Russian Federation
V. M. Labazanov
Russian Federation
References
1. Якобсон, И.М. Внепеченочные проявления хронического гепатита С / И.М. Якобсон [и др.] // Клин. гастроэнтерол. и гепатол. – 2011. – Т. 4, № 1. – С. 55–68.
2. Zignego, A.L. Extrahepatic manifestations of hepatitis C virus infection: A general overview and guidelines for a clinical approach / A.L. Zignego [et al.] // Dig. Liver Dis. – 2007. – V. 39. – P. 2–17.
3. Monti, G. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias / G. Monti [et al.] // Arch. Intern. Med. – 2005. – V. 165. – P. 101–105.
4. Fabrizi, F. Therapy of hepatitis C virus-associated glomerulonephritis: Current approaches / F. Fabrizi [et al.] // J. Nephrol. – 2008. – V. 21. – P. 813–825.
5. Harrison, S.A. Insulin resistance among patients with chronic hepatitis C: Etiology and impact on treatment / S.A. Harrison // Clin. Gastroenterol. Hepatol. – 2008. – V. 6.– P. 864–876.
6. Moucari, R. Insulin resistance in chronic hepatitis C: Association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis / R. Moucari [et al.] // Gastroenterol. – 2008. – V. 134. – P. 416–423.
7. Wang, C.S. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study /C.S. Wang [et al.] // Am. J. Epidemiol. – 2007. – V. 166. – P. 196–203.
8. Hsu, F.C. Prevalence of rheumatoid arthritis and hepatitis C in those age 60 and older in a US population based study / F.C. Hsu [et al.] // J. Rheumatol. – 2003. – V. 30. – P. 455–458.
9. Fox, R.I. Sjogren’s syndrome / R.I. Fox // Lancet. – 2005. – V. 366. – P. 321–331.
10. Leigh, J.P. Costs of hepatitis C / J.P. Leigh [et al.] //Arch. Intern. Med. – 2001. – V. 161. – P. 2231–2237.
11. Casato, M. Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: A multicenter case-control study using magnetic resonance imaging and neuropsychological tests / M. Casato [et al.] //J. Rheumatol. – 2005. – V. 32. – P. 484–488.
12. Spiegel, B.M. Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment /B.M. Spiegel [et al.] // Hepatology. – 2005. – V. 41. – P. 790–800.
13. Cacoub, P. Cryoglobulinemia vasculitis / P. Cacoub [et al.] // Curr. Opin. Rheumatol. – 2002. – V. 14, № 1. – P. 29–35.
14. Ferri, C. Cryoglobulins / C. Ferri, A.L. Zignego, S.A. Pileri // J. Clin. Pathol. – 2002. – V. 55, № 1. – P. 413.
15. Younossi, Z. The effects of HCV infection and management on health-related quality of life / Z. Younossi, J. Kallman // J. Hepatol. – 2007. – V. 45. – P. 806–816.
16. Ferri, C. Cryoglobulinemic vasculitis / C. Ferri, M.T. Mascia // Curr. Opin. Rheumatol. – 2006. – V. 18. – P. 54–63.
17. Saadoun, D. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis / D. Saadoun [et al.] // Curr. Opin. Rheumatol. – 2008. – V. 20. – P. 23–28.
18. Saadoun, D. Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy / D. Saadoun [et al.] // Rheumatol. – 2005. – V. 46. – P. 2917–2925.
19. Saadoun, D. Hepatitis C-associated mixed cryoglobulinemia: A crossroad between autoimmunity and lymphoproliferation / D. Saadoun [et al.] // Rheumatol. – 2007. – V. 52. – P. 1234–1242.
20. Cacoub, P. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemia vasculitis: Where do we stand? / P. Cacoub [et al.] // Ann. Rheum. Dis. – 2008. – V. 67. – P. 283–287.
21. Cavallo, R. Rituximab in cryoglobulinemic peripheral neuropathy / R. Cavallo [et al.] // J. Neurol. – 2009. – V. 256. – P. 1076–1082.
22. Saadoun, D. Rituximab plus peg-interferon/ribavirin compared to αpeg-interferon/ribavirin in hepatitis C related mixedα cryoglobulinemia / D. Saadoun [et al.] // Blood. – 2010. – V. 116. – P. 326–334.
23. Lamprecht, P. Cryoglobulinemic vasculitis /P. Lamprecht, A. Gause, W.L. Gross // Arthritis and rheumatism. – 1999. – V. 42, № 12. – P. 2507–2516.
24. Тишкевич, О.А. Системный цитомегаловирусный васкулит у ВИЧ-инфицированного больного / О.А. Тишкевич [и др.] // Эпидемиология и инфекционные болезни. – 2001. – № 1. – С. 31–36.
Review
For citations:
Sulima D.L., Gorchakova O.V., Sabadash N.V., Karev V.E., Labazanov V.M. Vasсulitis of skin at the patient with a chronic hepatitis C, the admixed сryoglobulinemia and activity current chronic CMV infection (the description of a clinical case). Journal Infectology. 2011;3(3):114-119. (In Russ.) https://doi.org/10.22625/2072-6732-2011-3-3-114-119